Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India US Equity Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Direct | Direct |
| Fund house | Nippon India | HDFC |
| NAV | ₹44.4608 | ₹23.6750 |
| NAV date | 19 Nov 2026 | 20 Nov 2026 |
| History | 11.3 years | 3.1 years |
| Expense ratio | 1.3% | 1.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 69.00 | 94.50 |
Returns
| Nippon India US Equity Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | −7.16% | +12.97% |
| 3 months | −7.52% | +7.13% |
| 6 months | −0.59% | +17.84% |
| YTD | +4.37% | +33.73% |
| 1 year | +11.57% | +32.20% |
| 3 years (CAGR) | +15.45% | +30.70% |
| 5 years (CAGR) | +9.43% | — |
| 10 years (CAGR) | +15.41% | — |
| Since launch | +14.39% | +31.83% |
Risk
| Nippon India US Equity Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 13.3% | 15.8% |
| Downside volatility | 8.1% | 8.5% |
| Sharpe | 0.68 | 1.53 |
| Sortino | 1.10 | 2.86 |
| Calmar | 0.83 | 2.06 |
| Return / risk | 1.17 | 1.95 |
| Deepest fall | −30.78% | −14.91% |
| Days to recover | 71 | 126 |
| Below its high | −9.28% | +0.00% |
Against benchmark
| Nippon India US Equity Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | +7.72% | +7.54% |
| Beta | 0.13 | 0.97 |
| R² | 2.4% | 85.0% |
| Up capture | 44.1% | 108.9% |
| Down capture | −14.7% | 71.0% |
| Tracking error | 19.2% | 6.1% |
| Information ratio | 0.16 | 1.17 |
| Treynor | 0.64 | 0.24 |
Consistency
| Nippon India US Equity Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +76.16% | +67.01% |
| Middle 1-year | +17.50% | +23.25% |
| Worst 1-year | −23.14% | +1.71% |
| 1-year periods with a loss | 10.7% | 0.0% |
| Middle 3-year | +17.07% | +30.22% |
| Positive months | 66.7% | 72.2% |
| Best day | +8.60% | +3.18% |
| Worst day | −5.13% | −3.61% |
| Worst 5% day | −1.53% | −1.51% |
| Positive days | 55.5% | 58.3% |
| NAVs a year | 240 | 247 |
SIP of ₹10,000 a month
| Nippon India US Equity Opportunities Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +13.59% | — |
| 5-year value | ₹8,49,020 | — |
| 3-year XIRR | +10.75% | +27.71% |
| 1-year XIRR | +1.82% | +41.37% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.